YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.
- DOI
- 10.1038/s41591-025-04029-3
- Published
- 2025 Dec
- Container
- Nature medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-04029-3,
title = {YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.},
author = {Yap TA and Kwiatkowski DJ and Dagogo-Jack I and Offin M and Zauderer MG and Kratzke R and Desai J and Body A and Millward M and Tolcher AW and Raghav KPS and Thurston A and Post L and Dorr FA and Tang TT and Li Y and Sharma N and Kindler HL},
year = {2025},
journal = {Nature medicine},
doi = {10.1038/s41591-025-04029-3},
url = {https://doi.org/10.1038/s41591-025-04029-3}
}RIS
TY - JOUR TI - YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial. AU - Yap TA AU - Kwiatkowski DJ AU - Dagogo-Jack I AU - Offin M AU - Zauderer MG AU - Kratzke R AU - Desai J AU - Body A AU - Millward M AU - Tolcher AW AU - Raghav KPS AU - Thurston A AU - Post L AU - Dorr FA AU - Tang TT AU - Li Y AU - Sharma N AU - Kindler HL PY - 2025 JO - Nature medicine DO - 10.1038/s41591-025-04029-3 UR - https://doi.org/10.1038/s41591-025-04029-3 ER -
APA
TA, Y., DJ, K., I, D., M, O., MG, Z., R, K., J, D., A, B., M, M., AW, T., KPS, R., A, T., L, P., FA, D., TT, T., Y, L., N, S., & HL, K. (2025). YAP/TEAD inhibitor VT3989 in solid tumors: a phase 1/2 trial.. Nature medicine. https://doi.org/10.1038/s41591-025-04029-3
Source records
- pubmed · retrieved 2026-09-25T18:18:35.032Z